$QCRH

QCR Holdings (NASDAQ: QCRH) president sells 310 shares at $91

BÖRSE TITAN rapporte que James D. Klein, Président de CRBT chez QCR Holdings Inc. (NASDAQ: QCRH), a vendu 310 actions ordinaires sur le marché libre à 91,00 $ l'action. Après cette transaction, il détient directement 428 actions et 5 838 actions supplémentaires via un compte géré. L'article détaille également les chiffres clés de la transaction, les définitions des termes financiers clés, et inclut le formulaire 4 de la SEC pour cette transaction, ainsi que des informations supplémentaires sur QCR Holdings.

Original reporting
Published May 1, 2026, 3:08 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 1, 2026, 3:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$QCRH
Bearish
medium confidence
Mentioned
$QCRH
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$QCRHBearishMed
01

Why it matters

While insider selling can be a cautionary sign, the small volume suggests limited concern. Investors should consider other fundamental factors.

02

Market read

The transaction has limited immediate impact on the stock's trading volume or price but warrants attention for short-term traders.

03

What to watch

Recent company performance, earnings reports, and broader market conditions could offset the impact of insider sales.

Timing: immediate (news published today)

Background

QCRH is a regional bank with a focus on community banking services. Insider transactions can provide insights into management's confidence.

Company-level read

Ticker impact

$QCRHBearishMedium confidence
Context

This insider transaction involves the company's president selling shares, which can be a signal of insider sentiment.

Expected impact

Potential slight downward pressure on QCRH stock in the short term.

Evidence & confidence

Insider sales can be a cautionary signal; however, the small number of shares sold relative to total holdings suggests limited impact. Market reaction will depend on broader context and investor perception.

Market effects

The financial services sector may experience minor negative sentiment due to insider sales in a regional bank.

Limited regional impact; primarily affecting investors in QCRH.

Negligible; this is a company-specific insider transaction with minimal global market influence.

Counterpoint

Insider sales do not always indicate negative outlook; executives may sell for personal reasons unrelated to company performance.

Key entities

  • QCR Holdings Inc.

    A regional bank providing banking and financial services.

  • James D. Klein

    President of CRBT at QCR Holdings, involved in the insider sale.

Related articles

$QCRHMed

QCR HOLDINGS INC (QCRH): Results of Operations and Financial Condition

QCR HOLDINGS INC (QCRH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 qcrh-20260722xex99d1.htm EX-99.1 Exhibit 99.1 PRESS RELEASE FOR IMMEDIATE RELEASE ​ QCR Holdings, Inc. Announces Net Income of $36.3 million for the Second Quarter of 2026 ​ ​ Second Quarter 2026 Highlights ​ ● Net income of $36.3 million, or $2.19 diluted earnings per

$ADBEMed

Adobe’s New CEO Takes Over in December. Is the Open CFO Search the Bigger Risk?

Adobe Inc. (ADBE) named Anil Chakravarthy as its next CEO, effective December 1, 2026. Shantanu Narayen will transition to executive chair. Stifel reiterated a Hold rating with a $200 price target, implying 25% downside. Q2 revenue was $6.62B, up 13% YoY. The CFO role remains interim. Hedge funds slightly reduced positions. Next earnings report is on September 10.

$AAPLLow

John Ternus Just Became Apple's CEO. In 6 Days, He Has to Prove It Matters.

John Ternus became Apple's CEO on September 1, 2026. He will oversee his first product event on September 9, featuring a foldable iPhone, new Apple Watches, and the launch of iOS 27 with Google's Gemini AI. Ternus, a hardware engineer, faces challenges in AI development and investor skepticism about Apple's AI strategy. Apple reported record revenue of $109.4 billion in Q2 2026 but saw a 9.4% stock drop due to weak guidance and AI concerns.

$NVSHighAI 9/10

Novartis, Ionis’ experimental heart drug misses key goal in trial

Novartis and Ionis Pharmaceuticals reported that their experimental heart drug, pelacarsen, failed to reduce the risk of major heart attacks and strokes in a late-stage trial. The drug, targeting genetically inherited cholesterol Lp(a), lowered Lp(a) levels but did not meet its primary endpoint. Novartis shares fell 5%, and Ionis shares dropped 12% in aftermarket trading. The companies plan to present full trial data at an upcoming medical congress.